Comparing to PAX5::ETV6, PAX5::ELN acts as a more potent initiating event to induce leukemia, with frequent acquisition of secondary mutations in Ptpn11, Jak3, and Kras genes in mice (58). Here, PAX5 is linked to leukemia.